With iPSCs, you can pick the cells from one donor, reprogram them, identify the best clone and then you have access to a stable iPSC line that you can use forever. Therefore, providing an endless ...

Two clonal lines are available for cell therapy developers and pharmaceutical companies as off-the-shelf products in both GMP and research-grade. (PRNewsfoto/I Peace, Inc.) I Peace's new iPSC line ...

Obviously, this is not an option in humans. “The only thing you can do for human iPSCs is take that cell line and put it into a teratoma assay in a mouse, and ask if the tumor tissues that form ...

Human iPSCs are a new type of pluripotent cell reprogrammed from patient or donor cells into versatile stem cells that can become any cell type. These iPSC-derived cells, which retain disease ...

Multiplexed-engineered, iPSC-derived CAR T Cell Targets Proteins Expressed on Cancer Cells in Response to Cellular Stress and Malignant ...

A new era of cell therapy has well and truly arrived with the iPSC field setting a trailblazing fire with its potential to develop fully scalable, off-the-shelf cell lines reducing the cost of ...

By leveraging the power of iPS cells to turn into nearly all cells ... examined whether a similar treatment of a commonly ...